Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.453NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.453NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.453NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.44NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.44NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.44NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.350NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.350NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.350NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.304NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.304NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.304NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.315NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.315NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.315NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.516NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.516NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.516NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.354NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.354NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.354NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.162NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.162NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.162NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.426NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.426NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.426NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.402NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.402NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.402NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.424NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.424NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.424NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.61NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.61NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.264NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.264NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.264NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.581NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.581NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.581NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.330NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.330NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.330NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.205NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.205NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.205NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.177NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.177NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used